Expression of ERAP2 (endoplasmic reticulum aminopeptidase 2), a pan-cancer gene associated with MHC-I antigen processing, predicted survival in bladder cancer patients receiving ICI therapy (120). Here, ERAP2 is linked to urinary bladder cancer.